Patents by Inventor Matthew Nodwell

Matthew Nodwell has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • 18F labeled amino acids, derivatives thereof and method of making same
    Patent number: 11534114
    Abstract: The present invention provides 18F-labeled amino acids or derivatives thereof having formula (I) and methods of making same, which can be suitable for PET imaging:
    Type: Grant
    Filed: August 23, 2017
    Date of Patent: December 27, 2022
    Assignee: Simon Fraser University
    Inventors: Paul Schaffer, Hua Yang, Robert Britton, Matthew Nodwell, Zheliang Yuan
  • 18F LABELED AMINO ACIDS, DERIVATIVES THEREOF AND METHOD OF MAKING SAME
    Publication number: 20190223814
    Abstract: The present invention provides 18F-labeled amino acids or derivatives thereof having formula (I) and methods of making same, which can be suitable for PET imaging:
    Type: Application
    Filed: August 23, 2017
    Publication date: July 25, 2019
    Inventors: Paul SCHAFFER, Hua YANG, Robert BRITTON, Matthew NODWELL, Zheliang YUAN
  • SHIP 1 MODULATOR COMPOUNDS
    Publication number: 20110263539
    Abstract: The present invention provides the use of pelorol analogs of Formula, (I) and pharmaceutical compositions thereof as modulators of SHIP 1 activity. A compound or a pharmaceutical composition of the present invention may be used for the treatment or prophylaxis of an inflammatory, neoplastic, hematopoetic or immune disorder or condition in addition to other disorders and conditions.
    Type: Application
    Filed: June 21, 2007
    Publication date: October 27, 2011
    Applicant: THE UNIVERSITY OF BRITISH COLUMBIA
    Inventors: Raymond Andersen, Matthew Nodwell, Alice Mui
  • Compositions of lipopeptide antibiotic derivatives and methods of use thereof
    Patent number: 7868135
    Abstract: The present invention provides derivatives of lipopeptide antibiotics that display antimicrobial activity against microorganisms, methods and compounds for synthesizing such antimicrobial derivatives and analogues, and methods of using the compounds in a variety of contexts, including in the treatment and prevention of microbial infections.
    Type: Grant
    Filed: June 28, 2004
    Date of Patent: January 11, 2011
    Assignee: Biowest Therapeutics Inc.
    Inventors: Dale R. Cameron, Vincent A. Boyd, Richard A. Leese, William V. Curran, Donald B. Borders, Paulo W. M. Sgarbi, Shirley A. Wacowich-Sgarbi, Matthew Nodwell, Yuchen Chen, Qi Jia, Dominique Dugourd
  • SHIP 1 MODULATOR PRODRUGS
    Publication number: 20100323990
    Abstract: The present invention provides the use of prodrugs of pelorol and homopelorol, related compounds and pharmaceutical compositions thereof as modulators of SHIP1 activity. A compound or a pharmaceutical composition of the present invention may be used for the treatment or prophylaxis of an inflammatory, neoplastic, hematopoetic or immune disorder or condition in addition to other disorders and conditions.
    Type: Application
    Filed: June 21, 2007
    Publication date: December 23, 2010
    Applicant: THE UNIVERSITY OF BRITISH COLUMBIA
    Inventors: Raymond Andersen, Matthew Nodwell, Alice Mui
  • Cross-linked glycopeptide-cephalosporin antibiotics
    Publication number: 20080108558
    Abstract: This invention provides cross-linked glycopeptide—cephalosporin compounds and pharmaceutically acceptable salts thereof which are useful as antibiotics. This invention also provides pharmaceutical compositions containing such compounds; methods for treating bacterial infections in a mammal using such compounds; and processes and intermediates useful for preparing such compounds.
    Type: Application
    Filed: October 25, 2007
    Publication date: May 8, 2008
    Inventors: Paul Fatheree, Martin Linsell, Daniel Long, Daniel Marquess, Edmund Moran, Matthew Nodwell, S. Derek Turner, James Aggen
  • Cross-linked glycopeptide - cephalosporin antibiotics
    Publication number: 20080103299
    Abstract: This invention provides cross-linked glycopeptide-cephalosporin compounds and pharmaceutically acceptable salts thereof which are useful as antibiotics. This invention also provides pharmaceutical compositions containing such compounds; methods for treating bacterial infections in a mammal using such compounds; and processes and intermediates useful for preparing such compounds.
    Type: Application
    Filed: December 19, 2007
    Publication date: May 1, 2008
    Inventors: Paul Fatheree, Martin Linsell, Daniel Marquess, Daniel Long, Jason Chinn, Matthew Nodwell, Edmund Moran, James Aggen
  • Cross-linked glycopeptide-cephalosporin antibiotics
    Publication number: 20080045721
    Abstract: This invention provides cross-linked glycopeptide-cephalosporin compounds and pharmaceutically acceptable salts thereof which are useful as antibiotics. This invention also provides pharmaceutical compositions containing such compounds; methods for treating bacterial infections in a mammal using such compounds; and processes and intermediates useful for preparing such compounds.
    Type: Application
    Filed: August 24, 2007
    Publication date: February 21, 2008
    Inventors: Paul Fatheree, Martin Linsell, Daniel Long, Daniel Marquess, Edmund Moran, Matthew Nodwell, S. Derek Turner, James Aggen
  • Cross-lined glycopeptide-cephalosporin antibiotics
    Publication number: 20080039374
    Abstract: This invention provides cross-linked glycopeptide—cephalosporin compounds and pharmaceutically acceptable salts thereof which are useful as antibiotics. This invention also provides pharmaceutical compositions containing such compounds; methods for treating bacterial infections in a mammal using such compounds; and processes and intermediates useful for preparing such compounds.
    Type: Application
    Filed: August 24, 2007
    Publication date: February 14, 2008
    Inventors: Paul Fatheree, Martin Linsell, Daniel Long, Daniel Marquess, Edmund Moran, Matthew Nodwell, S. Derek Turner, James Aggen
  • Cross-linked glycopeptide-cephalosporin antibiotics
    Publication number: 20080039611
    Abstract: This invention provides cross-linked glycopeptide—cephalosporin compounds and pharmaceutically acceptable salts thereof which are useful as antibiotics. This invention also provides pharmaceutical compositions containing such compounds; methods for treating bacterial infections in a mammal using such compounds; and processes and intermediates useful for preparing such compounds.
    Type: Application
    Filed: August 24, 2007
    Publication date: February 14, 2008
    Inventors: Paul Fatheree, Martin Linsell, Daniel Long, Daniel Marquess, Edmund Moran, Matthew Nodwell, S. Derek Turner, James Aggen
  • Aryl aniline beta2 adrenergic receptor agonists
    Publication number: 20070225329
    Abstract: The invention provides novel ?2 adrenergic receptor agonist compounds of formula (I): wherein R1-R13 and w have any of the values described in the specification. The invention also provides combinations of such compounds and other therapeutic agents, pharmaceutical compositions comprising such compounds and combinations, methods of using such compounds to treat diseases associated with ?2 adrenergic receptor activity, and processes and intermediates useful for preparing such compounds.
    Type: Application
    Filed: May 22, 2007
    Publication date: September 27, 2007
    Inventors: Edmund Moran, John Jacobsen, Michael Leadbetter, Matthew Nodwell, Sean Trapp, James Aggen, Timothy Church
  • Cross-linked glycopeptide-cephalosporin antibiotics
    Publication number: 20060128612
    Abstract: This invention provides cross-linked glycopeptide—cephalosporin compounds and pharmaceutically acceptable salts thereof which are useful as antibiotics. This invention also provides pharmaceutical compositions containing such compounds; methods for treating bacterial infections in a mammal using such compounds; and processes and intermediates useful for preparing such compounds.
    Type: Application
    Filed: January 30, 2006
    Publication date: June 15, 2006
    Inventors: Paul Fatheree, Martin Linsell, Daniel Marquess, Daniel Long, Jason Chinn, Matthew Nodwell, Edmund Moran, James Aggen
  • Cross-linked glycopeptide - cephalosporin antibiotics
    Publication number: 20050239691
    Abstract: This invention provides cross-linked glycopeptide-cephalosporin compounds and pharmaceutically acceptable salts thereof which are useful as antibiotics. This invention also provides pharmaceutical compositions containing such compounds; methods for treating bacterial infections in a mammal using such compounds; and processes and intermediates useful for preparing such compounds.
    Type: Application
    Filed: June 30, 2005
    Publication date: October 27, 2005
    Inventors: Paul Fatheree, Martin Linsell, Daniel Long, Daniel Marquess, Edmund Moran, Matthew Nodwell, S. Turner, James Aggen